Get started
Author

Katarína Hajduová

Observed names: Hajduova, Katarina, Hajduová, Katarína, K Hajduová, Katarina Hajduova
ORCID: 0009-0000-3078-0907
Observed ORCID: 0009-0000-3078-0907
OpenAlex ID: A5116594034
It’s a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies
2025 · Johanna Trommer, Martin Ullrich, et al. · EJNMMI Radiopharmacy and Chemistry · 13
PDF
Positron Emission Tomography Imaging of Acinetobacter baumannii Infection: Comparison of Gallium-68 Labeled Siderophores
2025 · Katerina Dvorakova Bendova, Kristyna Krasulova, et al. · ACS Infectious Diseases · 12
In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac
2025 · Kateřina Ondrák Fialová, Lukáš Ondrák, et al. · EJNMMI Radiopharmacy and Chemistry · 4
PDF
Paving the way for future PSMA inhibitors: insights from comparative preclinical evaluations of structure modifications
2025 · Katarína Hajduová, Kateřina Dvořáková Bendová, et al. · EJNMMI Radiopharmacy and Chemistry · 1
Targeted PET Imaging of Pseudomonas aeruginosa Using a [ 68 Ga]Ga-Pyoverdines Cocktail
2026 · Kristyna Krasulova, Barbora Neuzilova, et al. · Journal of Nuclear Medicine
Comparative Pet/ct Imaging of Bacterial Infection: Ferrioxamine E Vs. Its Derivative Ferrioxamine 2-5
2026 · Kateřina Dvořáková Bendová, Barbora Neuzilova, et al. · EANM Innovation
Preclinical Evaluation of 203Pb- and 212Pb-Labeled mcp-PSMA Ligands for Radionuclide Theranostics of Prostate Cancer
2025 · Magdalena Blei, Katarína Hajduová, et al. · Nuclear Medicine and Biology
Präklinische Bewertung von 203/212Pb-markierten mcp-PSMA-Liganden für die Bildgebung und Therapie von Prostatakrebs und PSMA-positiven Krebszellen
2025 · M K Blei, K Hajduová, et al. · Nuklearmedizin - NuclearMedicine
Works count: 14
Citation count: 30
H-index: 3
I10-index: 2
Year
Topic
Type